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Abstract
Background: The Sertoli cells act to induce testis differentiation and subsequent development in fetal and post-natal
life which makes them key to an understanding of testis biology. As a major step towards characterisation of factors
involved in Sertoli cell function we have identified Sertoli cell-specific transcripts in the mouse testis and have used the
data to identify Sertoli cell-specific transcripts altered in mice lacking follicle-stimulating hormone receptors (FSHRKO)
and/or androgen receptors (AR) in the Sertoli cells (SCARKO).
Results: Adult iDTR mice were injected with busulfan to ablate the germ cells and 50 days later they were treated with
diphtheria toxin (DTX) to ablate the Sertoli cells. RNAseq carried out on testes from control, busulfan-treated and busulfan
+ DTX-treated mice identified 701 Sertoli-specific transcripts and 4302 germ cell-specific transcripts. This data was mapped
against results from microarrays using testicular mRNA from 20 day-old FSHRKO, SCARKO and FSHRKO.SCARKO mice.
Results show that of the 534 Sertoli cell-specific transcripts present on the gene chips, 85% were altered in the FSHRKO
mice and 94% in the SCARKO mice (mostly reduced in both cases). In the FSHRKO.SCARKO mice additive or synergistic
effects were seen for most transcripts. Age-dependent studies on a selected number of Sertoli cell-specific transcripts,
showed that the marked effects in the FSHRKO at 20 days had largely disappeared by adulthood although synergistic
effects of FSHR and AR knockout were seen.
Conclusions: These studies have identified the Sertoli cell-specific transcriptome in the mouse testis and have shown
that most genes in the transcriptome are FSH- and androgen-dependent at puberty although the importance of FSH
diminishes towards adulthood.
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Background
The development and function of the testis is critically
dependent on the Sertoli cells. These cells initially
differentiate from the coelomic epithelium, at around
embryonic day 11.5 (e11.5) in the mouse, and act to
induce formation of the seminiferous tubules and the fetal
Leydig cell population [1]. Post-natally, the Sertoli cells
are essential for spermatogenesis and cell ablation studies
have shown that the Sertoli cells are also required for
development and maintenance of both the adult Leydig
cells and peritubular myoid cells and for normal develop-
ment of the testicular vasculature [2–4]. Some specific
pathways involved in these cell-cell interactions have been
identified, such as the role of DHH in Leydig cell develop-
ment [5, 6] but, in most cases, the cellular and molecular
mechanisms by which the Sertoli cells exert control over
testis development and function are unknown. Given the
central role of the Sertoli cell in testis biology, identifica-
tion of these pathways has to be a high priority for current
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research, particularly with respect to androgen produc-
tion, ageing and adult male health [7, 8]. A step towards
this goal would be identification of Sertoli cell-specific
transcripts – ie those testicular transcripts that are only
expressed in the Sertoli cells and are likely, therefore, to
be involved in Sertoli-specific functions. Previously, we
have shown that cell ablation can be used to identify cell-
specific transcripts [9] and so we have now used the
recently described diphtheria toxin (DTX) model of
Sertoli cell ablation [3] to identify Sertoli cell-specific tran-
scripts using RNAseq. As previously [9], one confounding
factor in identifying cell-specific transcript expression
through cell ablation studies in the testis is the loss of
germ cells coincident with Sertoli cell ablation [2]. To
circumvent this problem, we have used busulfan to gener-
ate a germ cell-free mouse prior to Sertoli cell ablation [9].
This also has the added advantage that comparison
between normal mice and busulfan-treated animals allows
identification of germ cell-specific transcripts.
During post-natal development, and in the adult, the
Sertoli cells are regulated by follicle stimulating hormone
(FSH) and androgen [10]. In the absence of FSH, or the
FSH-receptor (FSHR), Sertoli cell number and germ cell
number is reduced although the animals are fertile [11, 12].
In animals lacking androgen receptors (AR) specifically on
the Sertoli cells (SCARKO) the Sertoli cell number is
normal but spermatogenesis is blocked at meiosis and the
animals are infertile [13]. Double knockout of both the
FSHR and AR in the Sertoli cells has a synergistic effect
leading to a marked failure in germ cell development and
spermatogenesis [14]. There have been a number of studies
which have examined global changes in transcript levels in
ARKO and SCARKO mice but there has been no strong
consensus about the transcripts affected in these animals
[15]. This may be partly because these studies are con-
founded by changes in germ cell-specific transcript levels as
a result of the disruption to spermatogenesis. There have,
to date, been no studies of changes in overall transcript
levels in FSHRKO mice or in combined FSHRKO.SCARKO
mice. Identification of Sertoli cell-specific genes affected by
FSHR, AR and FSHR+AR knockout would be an import-
ant step forward in understanding how FSH and androgen
regulate the Sertoli cells and, in turn, how the Sertoli cells
regulate testis function. We have therefore carried out
microarray studies on control, FSHRKO, SCARKO and
FSHRKO.SCARKO mice and integrated the data with the
cohort of Sertoli cell-specific genes identified by cell abla-
tion. This has allowed is to identify Sertoli cell specific tran-
scripts altered in the different mouse models.
Methods
Animals and treatments
All animal maintenance and handling followed U.K. Home
Office regulations and all animal procedures were carried
out under U.K. Home Office License and with the approval
of local ethical review committees at the Universities of
Glasgow, Edinburgh and Oxford. FSHRKO, SCARKO and
FSHRKO.SCARKO mice were generated at the University
of Oxford as published previously [16] from mice obtained
originally from Prof G Verhoeven and Dr. K De Gendt
(Catholic University of Leuven, Belgium) and from mouse
colonies bred at the University of Oxford [16]. Mice were
killed at 1d, 5d, 20d and 8 weeks of age and testes stored in
liquid N2 until used for microarray studies or qPCR. Amh-
Cre;iDTR mice (referred to as iDTR mice), which carry the
diphtheria toxin receptor (DTR) specifically in the Sertoli
cells, were generated as described previously [2, 3] from
mice originally obtained from Professor A Waisman
(through the Jackson Laboratories, Maine, USA) and from
Professor F Guillou (Université de Tours, France). Adult
iDTR mice (>120 days) were injected once with busulfan
(30 mg/Kg) or vehicle [2, 17] and 50 days later they were
injected with DTX (100 ng) or vehicle. Animals were killed
7 days later and one testis from each animal was frozen and
stored in liquid N2. To confirm identification of Sertoli cell
transcripts from RNAseq data, mRNA was used from a
cohort of adult iDTR mice described previously [2]. These
animals were injected once with DTX only (without
busulfan treatment) and were killed 7d, 30d, 90d or 1 year
later. Similarly, to confirm identification of germ cell
transcripts from RNAseq data, mRNA was used from
control mice (purchased from Harlan UK, Bicester, UK)
treated once with busulfan and killed at different times up
to 50 days later [17]. Finally, control, untreated mice
from a different colony (bred at the University of
Glasgow) [18] were used to examine normal develop-
ment of transcript expression.
RNAseq
RNA was extracted from whole testes of individual
animals using RNAeasy kits with on-column DNAse
treatment (Qiagen Ltd., Manchester, UK). Polyadeny-
lated RNA Sequence libraries were constructed using
the Illumina TruSeq Stranded mRNA sample prep kit
(Illumina, Cambridge, UK). The library was single-end
sequenced on an Illumina NextSeq 500 with the Next-
Seq 500/550 High Output kit version 2 for 75 sequence
cycles. Sequencing depth averaged 43.7 million reads per
sample (range 31.6–61.2). The sequence reads were fil-
tered for low quality bases and contaminating adapter
sequences using Cutadapt [19] (version 1.5). The
quality-trimmed reads were aligned to the mouse gen-
ome (version GRCm38.p4) using HiSat [20] (version
0.1.2-beta) and mean alignment per sample was 96.9%
(range 96.1–97.5%). Differential expression analysis was
performed using Cuffdiff [21] for the Cufflinks package
[22]. The bioconductor package cummeRbund [23] was
used to investigate the output from the Cuffdiff package.
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Identification of signal peptides in transcripts of interest
was carried out by manual curation of relevant NCBI
GenBank files (https://www.ncbi.nlm.nih.gov/genbank/)
while secreted proteins were identified through
comparison with a database downloaded from the
Human Protein Atlas (https://www.proteinatlas.org/
search/protein_class:Predicted%20secreted%20proteins).
Microarrays
Microarrays were carried out using RNA extracted from
whole testes of 20-day old FSHRKO, SCARKO,
FSHRKO.SCARKO and control mice. RNA from testes
of individual animals was extracted using RNeasy kits
(Qiagen Ltd., Manchester, UK). Samples of total RNA
(8μg) from individual animals (4 per group) were reverse
transcribed and then in vitro transcribed and hybridised
to mouse MOE430A arrays (Affymetrix, Santa Clara,
CA, USA) according to the GeneChip expression tech-
nical manual (Affymetrix, Santa Clara, CA, USA) as pre-
viously reported [24]. Gene transcript levels were
determined from data image files using algorithms in
Gene Chip Operating Software (GCOS1.2, Affymetrix).
Data were normalised to testis volume and Sertoli cell
number as described in Results (Additional file 1). Array
data and RNAseq data were aligned using a relational
database (Access, Microsoft Corp, Washington, USA)
using the gene symbols to connect the databases. This
allowed Sertoli cell-specific transcripts on the arrays to
be identified.
Real-time PCR
Testis RNA was extracted using Trizol (Life Technolo-
gies, Paisley, UK) and levels of specific mRNA species
were measured by real-time PCR. Total RNA was
reverse transcribed using random hexamers and
Moloney murine leukaemia virus reverse transcriptase
(Superscript III, Fisher Scientific UK Ltd., Loughbor-
ough, UK) as described previously [25]. To normalise
the data, external standard (luciferase mRNA: Promega
UK, Southampton, UK) was added to each testis at the
start of the RNA extraction [26]. For real-time PCR the
SYBR green method was used with SYBR mastermix
(Agilent Technologies, Wokingham, UK) [27]. All
primers were designed by Primer Express 2.0 (Applied
Biosystems, Warrington, UK) or Primer-BLAST (https://
blast.ncbi.nlm.nih.gov/Blast.cgi) using parameters previ-
ously described [28] and the primers used are described
in Additional file 2. Transcript levels were normalised to
the luciferase external standard, which generates a
relative value of transcript expression per testis [29].
Statistical analysis
Data from the arrays were analyzed using two-factor
analysis of variance (ANOVA) with each gene knock-out
(FSHRKO or SCARKO) as one of the factors. Where the
interaction between the factors was significant, this means
that the effect of the double knockout (FSHRKO.S-
CARKO) was not simply an additive effect of each gene
knockout alone. Where there was no significant
interaction P values were taken directly from the ANOVA.
Where the interaction was significant, post-hoc testing
was used to calculate P values for FSHRKO and SCARKO
groups. The significance of differences between groups in
the RNAseq were calculated by t-test or single factor
ANOVA. In all cases, differences between groups were
considered significant with P < 0.05 and with the false
discovery rate (FDR) = 0.05 [30]. Real-time PCR data was
analysed using single factor or two-factor ANOVA.
Results
Effects of busulfan and DTX on the testis transcriptome
RNAseq analysis of testis transcript expression in
control, busulfan-treated and busulfan + DTX-treated
mice identified 25,255 transcripts which were detectable
in at least one group (Additional file 3). Treatment of
iDTR mice with busulfan caused a significant (P < 0.05,
FDR = 0.05) change in the expression of 18,095 tran-
scripts compared to control (6961 transcripts increased,
11,134 transcripts decreased; Additional file 4) while
treatment with busulfan followed by DTX caused a
significant change in levels of 5280 transcripts compared
to busulfan alone (2891 transcripts increased and 2389
transcripts decreased; Additional file 4). Since treat-
ments with busulfan and with DTX will specifically
target germ cells and Sertoli cells respectively (with close
to 100% efficiency) then transcripts markedly reduced
following each treatment regime are highly likely to be
germ cell- or Sertoli cell-specific. The only probable
exceptions will be transcripts in another cell type which
are highly dependent on the germ cells or Sertoli cells
and which may be wrongly categorised as germ cell- or
Sertoli cell-specific if their expression drops markedly
after cell ablation. This is discussed further below but
we would not anticipate numbers of such transcripts to
be large. Transcripts in the RNAseq database that show
a less-marked response to cell ablation (eg 30–70%
decrease) are likely to be expressed in more than one
cell type and so data in Additional file 4 should be
treated with caution and should be cross-referenced to
Additional file 3.
As a proof of concept that cell ablation will identify
cell-specific transcripts, transcript data (from the
RNAseq study) for a number of known germ cell-,
Leydig cell- and Sertoli cell-specific genes are shown in
Fig. 1a-c. The known germ cell-specific genes showed
the expected marked reduction in transcript numbers
following busulfan treatment (Fig. 1a). Leydig cell-
specific genes showed a significant increase in transcript
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levels after busulfan treatment and in some cases a
further increase after DTX (Fig. 1b). The increase in
transcript levels after busulfan is due largely to relative
enrichment of somatic cells in the testis after germ cell
ablation and the same effect is seen with Sertoli cell spe-
cific genes (Fig. 1c). This also explains the number of
Fig. 1 Data from RNAseq study showing transcript expression in control, busufan-treated and busulfan + DTX-treated mice. Data shows expression of
known germ-cell transcripts (a), Leydig cell transcripts (b) and Sertoli cell transcripts (c). Results show mean ± SEM of 4 or 5 animals per group. In (d)
data from all transcripts detected in the RNAseq study is shown as the transcript number log ratio of DTX + busulfan/ busulfan alone (log2 fold-change
DTX (+bus)) plotted against the log ratio of busulfan alone/control (log2 fold-change busufan). Known germ cell transcripts from a) are shown in blue,
Leydig cell transcripts from b) are shown in purple and Sertoli cell transcripts from c) are shown in red. When transcript expression in the DTX +
busulfan group was zero the log2 fold-change DTX (+bus) could not be calculated and the points are indicated by a red arrow. In a) to c) groups with
different letter superscripts are significantly (P < 0.05) different
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transcripts significantly increased after busulfan or DTX
treatment (Additional file 4). The average enrichment
factor after busulfan treatment, measured from 25
known somatic genes, was 6.49-fold although there was
a wide range (2.92–11.94 fold). The wide range probably
results from effects of germ cell depletion on somatic
cell gene expression [17]. The increase in Leydig cell
transcript number after DTX is due to further enrich-
ment caused by Sertoli cell ablation and, in some cases,
to a likely change in Leydig cell function following Ser-
toli cell ablation [2]. In contrast to Leydig cell tran-
scripts, treatment with DTX led to an expected and
marked decrease in Sertoli cell-specific transcript num-
bers (Fig. 1c). There was some variation in this response
which is likely to be an indication that some known Ser-
toli cell transcripts (eg Wt1) are also expressed to a
small extent in other somatic cells. Figure 1d is a scatter
plot showing all transcripts from the RNAseq study
expressed as fold-change in transcript level following bu-
sulfan (relative to control) vs fold change following bu-
sulfan + DTX (relative to busulfan alone). The fold
changes in the 8 known Sertoli cell-specific genes (in
red), 4 Leydig cell genes (in purple) and 4 germ cell
genes (in blue), shown in Fig. 1a-c, are highlighted in
Fig. 1d. The three sets of transcripts form distinct clus-
ters on the diagram (Fig. 1d) with more spread apparent
in the Sertoli cell cluster reflecting the variation seen in
Fig. 1c.
Identification of Sertoli cell-specific transcripts
From the data in Fig. 1d it is clear that different levels of
stringency can be applied to the identification of Sertoli
cell-specific genes. At the highest level of stringency,
selecting only genes which show a greater than 5-fold
increase in transcript number after busulfan followed by a
90% decrease in transcripts after DTX, identifies 114 tran-
scripts. It is clear, however, that these cutoff limits will
miss a significant portion of known Sertoli cell genes. We
have, therefore, chosen less stringent criteria - more than
2 fold increase after busulfan and a 70% decrease (−3.3
fold) after DTX (and a significant effect of busulfan or
busulfan + DTX) – to ensure that we identify most Sertoli
cell-specific transcripts. This identifies 701 transcript
species (Additional file 5) which fulfill the criteria and
show a significant (P < 0.05, FDR = 0.05) reduction after
DTX treatment. This list contains 495 protein-coding
genes, 121 non-coding RNAs, 44 predicted pseudogenes
and 41 other unclassified transcripts (Additional file 5).
The disadvantage to using less stringent criteria is that
transcripts decreased 70–80% after DTX are likely to be
expressed at low levels in other testicular cells. Conversely,
this is a list of transcripts highly enriched in the Sertoli
cells which can be used to interrogate other databases and
it is likely to include the overwhelming majority of Sertoli
cell-specific transcripts. The data in Additional file 3 also
allows investigators to apply more or less stringent criteria
as necessary. Finally, the complete RNAseq dataset
(Additional file 3) can be used to assess whether any gene
of interest is likely to show Sertoli cell expression, even if
it is expressed in more than one testicular cell type. For
example, none of the platelet-derived growth factors or
their receptors show any decrease in expression after
DTX treatment suggesting there is little or no expression
in adult mouse Sertoli cells [31]. Similarly, inhibin/activin
subunits have been reported to be expressed in several cell
types in the testis [32] and data in Additional file 3
indicates that Inhbb is primarily a Sertoli cell product in
the adult testis while Inhba is primarily expressed in
somatic cells but not the Sertoli cells. As a final example,
there is some uncertainty about Sox13 expression in the
testis with spermatogonia, spermatocytes, Sertoli cells and
Leydig cells suggested as possible sites [33–35]. Analysis
of the RNAseq data shows that expression increases ~5-
fold after busulfan and decreases about 30% after DTX.
This would indicate that in the mouse Sox13 is not
expressed in the germ cells, shows some expression in the
Sertoli cells but is mostly expressed in another
somatic cell type. Differences to other studies which
used the rat [33, 34] may be due species-dependent
variation in transcript localisation.
To confirm the data from the RNAseq analysis 10 genes
were chosen for further analysis by qPCR. These transcripts
represent different levels of fold-change in expression after
DTX and transcript levels were measured in testes from
iDTR mice (without prior busulfan treatment) at different
times after DTX treatment (Fig. 2). At 7 days after DTX
treatment there was a clear and marked reduction in all
transcript levels and the fold change after DTX was similar
whether measured by qPCR or RNAseq with the exception
of Epha8 which showed a less marked reduction by qPCR.
This confirms the reliability of data in Additional file 5 and
shows that the changes in transcript levels after DTX are
independent of previous exposure to busulfan. Expression
levels of most of the Sertoli cell transcripts remained very
low, and in some cased decreased further, up to 1 year after
DTX treatment. In two interesting cases (Etd and Defb36)
there was a transient increase in expression 30d after DTX
treatment. This shows that other testicular cells had started
expressing these transcripts at this time, a phenomenon
that has been described previously following Leydig cell ab-
lation [36]. Normal developmental changes in the same 10
Sertoli cell-specific transcripts are shown in Additional file 6
along with changes in the known Sertoli cell genes Rhox5,
Cldn11 and Amh. Most transcripts showed a developmen-
tal pattern similar to Rhox5 (gradual developmental in-
crease with more marked increase towards adulthood) or
Cldn11 (marked increase on day 10 with sustained high
levels up to adulthood).
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Functional analysis of Sertoli cell-specific transcripts
Potential protein/gene network interactions among
the Sertoli cell-specific transcripts identified by the
online “Search Tool for the Retrieval of Interacting
Genes/Proteins” (STRING, http://www.string-db.org)
[37] are shown in Additional file 7. Functional
analysis shows significant enrichment for 46 func-
tional pathways within the set of Sertoli cell-specific
transcripts, 20 cellular component pathways and 1
KEGG pathway (Additional file 8). A number of these
enriched pathways/components are associated with
known Sertoli cell specific functions such as junc-
tional signalling and cell secretion and transport. It is
also notable that the list of Sertoli cell specific
transcripts includes 42 encoding different receptors,
including VDR, FSHR, ADORA1, NR0B1 (DAX1) and
AGTR2 (Additional file 9), while 111 of the translated
proteins are predicted to have signal peptides and 72
Fig. 2 qPCR verification of selected RNAseq data. Ten transcripts were selected from the Sertoli cell specific group in Additional file 5 and expression
was measured in iDTR mice 7, 30, 90 and 365 days after a single injection of DTX. The mean ± SEM is shown with 4–7 animals per group. For direct
comparison, the transcript levels at day 7 (expressed as a percentage of control levels) are shown beside each graph for both RNAseq and qPCR data.
Transcript species Etd, Slc9a2, Peg10, Pde4b and Aqp8 showed significant (P < 0.05) age-dependent differences between controls
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may be secreted by the cells (Additional file 9). This
list of 72 secreted proteins includes 10 which do not
have a signal peptide and so must be secreted
through non-classical secretory pathways [38]. Inter-
estingly, the one KEGG pathway significantly enriched
is for axon guidance while biological processes associ-
ated with neural signalling are also enriched. This is
consistent with the reported ability of Sertoli cells to
promote neuronal differentiation and survival in co-
cultures and co-grafts [39] although the normal
physiological importance of this is not clear beyond
the high potential for the Sertoli cells to secrete
trophic factors.
Identification of germ cell-specific transcripts
In the same way that Sertoli cell specific genes have
been identified by Sertoli cell ablation it is possible
through a comparison between control testes and
busulfan-treated testes to identify germ cell-specific
transcripts. Busulfan acts by inducing apoptosis in
spermatogonia within 1 week of treatment [40] and
germ cells are then gradually lost from the testis over a
25–30 day period as remaining cells mature, are
released from the testis and are not replaced. At the
timepoint chosen for this study (50 days after busulfan)
the testes are largely devoid of germ cells although
some tubules contain small pockets of regenerating
germ cells [17]. It is unlikely that these regenerating
cells would have a marked effect on identification of
germ cell genes given the small numbers but they may
cause some genes (eg those highly expressed early in
regeneration) to fall outside the criteria for selection.
Selecting genes that show a significant >90% reduction
in transcript levels after busulfan treatment identifies
4302 genes (Additional file 10) which includes a large
number (2274) of uncharacterised genes. This is a fairly
stringent approach and less stringent cutoffs can be
applied to the data in Additional file 3. With the cutoff
set at >90% reduction in transcript levels, it is highly
likely that the vast majority of genes in Additional file 10
are of specific germ cell origin and the most highly
expressed of these genes are the protamines and
transition proteins. Changes in transcript levels of 4
selected germ cell-specific genes at different times after
a single injection of busulfan are shown in
Additional file 11. For 2 genes (Nmur1 and Chn2)
expression did not change until 30 days after busulfan
injection indicating that these transcripts are
expressed primarily in spermatids [17]. The remaining
genes (Sofu and Osbp2) started to show a change in
transcript levels around days 15–20 suggesting
expression in spermatocytes.
Potential protein/gene network interactions among
the germ cell-specific transcripts identified by
STRING are shown in Additional file 12. Due to
limitations on the number of genes/proteins that can
be analysed by STRING only transcripts with average
control expression >3 FPKM (2838 transcript species)
were included, of which STRING recognised 1915
genes/proteins. Functional analysis shows significant
enrichment for 36 functional pathways within the set
of germ cell-specific transcripts, 35 cellular
component pathways, 9 PFAM protein domains and
14 INTERPRO protein domains and features
(Additional file 13). Most of these enriched pathways
are associated with known germ cell-specific functions
or features.
Comparison to previously published Sertoli cell-specific
gene lists
Previous studies have described the Sertoli cell transcrip-
tome through the use of RiboTag mice or FACS [41–43]
although there is little agreement between studies on
what constitutes the Sertoli cell transcriptome. To
determine whether there is a consensus between Sertoli
cell-specific genes identified in this study and those
identified by other groups using different methods we
have mapped the genes from different studies to the
results of the RNAseq (Additional file 14). Sanz et al.
[41] identified 2430 Sertoli cell specific/enriched genes
by RiboTag analysis and, of these, 448 show a 70% or
greater decrease after DTX in our studies and 315 would
satisfy the criteria of 2-fold increase after busulfan and
70% decrease after DTX (Additional file 14). De Gendt
et al. [42] also used a RiboTag approach and identified
508 Sertoli cell-specific genes. Of these genes, 177 show
a 70% decrease after DTX in our study and 122 would
satisfy the criteria of 2-fold increase after busulfan and
70% decrease after DTX (Additional file 14). Using cell
sorting techniques Zimmerman et al. [43] identified
8459 genes expressed in the Sertoli cell although this list
is not Sertoli cell-specific; rather, it is a list of all genes
expressed in the Sertoli cells and so contains genes
expressed in other testicular cell types (eg Actb
(β-actin)). Of the 495 protein-coding genes identified
above as Sertoli cell-specific through DTX ablation
(Additional file 5), 317 are also identified in the Sertoli
cell list reported by Zimmerman et al. [43]. In contrast
to protein-coding genes, only 18 of the non-coding/un-
classified genes identified using DTX are also included
in [43]. Comparing all 4 datasets (Additional file 5, two
RiboTag datasets [41, 42] and the data in [43]) there are
83 transcripts that appear in all (Additional file 15). This
may be considered as a baseline list of Sertoli cell-
specific transcripts but must be considered to be highly
conservative and treated with caution as it does not
include some known Sertoli cell-specific transcripts such
as Rhox5, Amh, Sox9, and Gdnf.
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Identification of FSH- and androgen-regulated Sertoli cell-
specific transcripts
To identify Sertoli cell-specific genes regulated by FSH
and androgen, microarrays were carried out using RNA
extracted from 20-day old control, FSHRKO, SCARKO
and FSHRKO.SCARKO mice. All data from the arrays is
shown in Additional file 16 and data from Sertoli cell-
specific transcripts only is shown in Additional file 17.
In total, 539 Sertoli cell-specific transcripts, identified by
RNAseq as above, were also present on the gene-chips
used for the arrays.
It has been shown previously that testis volume and
Sertoli cell number differ significantly between the con-
trol and transgenic mouse groups used in this study
[16] with the consequence that there is enrichment for
Sertoli cell mRNA in total testicular mRNA from all
groups relative to control animals (ie Sertoli cell mRNA
will make up a greater proportion of total testis
mRNA). To compare Sertoli cell transcript levels in the
different mouse groups it is necessary, therefore, to
normalise the array data to take into account testis vol-
ume and Sertoli cell number as previously described
[44]. The Sertoli cell mRNA enrichment factor for each
group was calculated as [Sertoli cell number in group
X/testis volume group X]/[control Sertoli cell number/
control volume] (where group X is FSHRKO, SCARKO
or FSHRKO.SCARKO) using data from [16] (Additional
file 1). Array data in Additional file 17 were normalised
for Sertoli cell numbers by dividing by the enrichment
factor (Additional file 1). Overall, the effects of the
FSHR and the Sertoli cell AR knockouts was to
decrease the level of most Sertoli cell-specific tran-
scripts with a more marked effect in the double knock-
out (Fig. 3 and Additional file 17). More specifically,
510 Sertoli cell transcripts were significantly altered in
the FSHRKO mouse and, of these, 509 were down regu-
lated and only one (Igfbp3) significantly up regulated
(Additional file 17). The most affected transcripts
(Emb, Dmrtc1b, Aqp8) showed a 80–85% decrease in
FSHRKO mice. In SCARKO mice 468 transcripts were
significantly altered with 461 transcripts significantly
decreased and 7 significantly increased. The greatest in-
crease (2-fold) was in Clca2 while the biggest decreases
(80–90%) were in Aqp8, Gm648 and Corin. Analysis
showed that there was no significant interaction
between the factors (FSHRKO and SCARKO) in 251
transcripts which means that any effects of FSHRKO
and SCARKO were additive in the FSHRKO.SCARKO
mouse. The significant interaction seen in 288 tran-
scripts means that in the FSHRKO.SCARKO mouse the
effect of the double knockout was not the predicted
additive effects of the individual knockouts (ie there
was either a significant synergistic effect of the double
knockout or the double knockout was significantly less
than the additive effects of the individual knockouts).
In those transcripts showing a significant interaction
there were 7 that showed a marked (>90%) decrease in
the FSHRKO.SCARKO mice (Emb, Aqp8, Dmrtc1b,
Gm648, Nxf3, Corin, Slc9a2) (Additional file 17). No
transcript showed both an overall increase in the
FSHRKO.SCARKO mice and a significant interaction
between factors.
The array studies used 20-day old mice for reasons
previously described [44]; briefly, this age was chosen
because Sertoli cell proliferation has ceased and it is the
first age at which Sertoli cells are likely to be showing an
adult phenotype, it is prior to normal testicular descent
and germ cell numbers have not yet reached adult levels
(although the lack of more mature germ cells (eg
spermatids) will alter cell signalling within the tubule). In
order, therefore, to determine whether transcript
expression in the adult shows similar dependence on
hormonal stimulation to 20-day old animals, the expres-
sion of 10 Sertoli cell-specific genes was measured by
qPCR in adult control, FSHRKO, SCARKO and
FSHRKO.SCARKO mice. The transcripts chosen for
further study represented a cross-section of transcript
differences in the FSHRKO and SCARKO testes as
measured by the microarrays. The qPCR used an external
standard (luciferase) for normalisation so that there was
no requirement to correct for testis volume and the
results are corrected only for Sertoli cell number [16]. For
comparison, data in Fig. 4 shows results from the arrays
on day 20 animals and the qPCR studies on the adult
animals. In general, transcript differences seen in adult
SCARKO and FSHRKO.SCARKO mice were very similar
to those seen at day 20 (Fig. 3). There was less agreement,
however, in the FSHRKO mice with the effects of the
knockout at day 20 more marked than in the adult. To
Fig. 3 Summary of array data. Results show the change in expression
(relative to control) of all Sertoli-cell specific transcripts in FSHRKO,
SCARKO and FSHRKO.SCARKO mice at 20 days when normalised to
Sertoli cell number. Each point represents a specific transcript species.
The mean change of all transcripts in each group is shown as a
red line
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confirm these differences we measured transcript expres-
sion in FSHRKO mice of different ages by qPCR (Fig. 5).
Results show that the effects of the FSHR knockout are
much greater at day 20 (as predicted by the arrays) than in
the adult indicating that the Sertoli cells can largely adapt
to loss of the FSHR in the adult.
Fig. 4 Selected transcript levels at day 20 and adulthood in FSHRKO, SCARKO and FSHRKO.SCARKO mice. Transcript levels were measured by RNAseq
or qPCR as indicated and results show the mean ± SEM (n = 3–6 animals per group). Expression data has been normalised to Sertoli cell number for
each group. Data was analysed initially by 2-factor ANOVA and then by Tukey’s post-hoc test. Where an interaction is indicated this means that the
effect of the double knockout (FSHRKO.SCARKO) is significantly different from the additive effects of each individual knockout. Groups with different
letter superscripts are significantly (P < 0.05) different
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Fig. 5 Developmental changes in transcript expression levels in control and FSHRKO mice measured by qPCR. Results show mean ± SEM of 3–6
animals per group. A significant (P < 0.05) difference between control and FSHRKO groups at a particular age is shown by an asterisk (*).
Expression of Igfbp3 and Slc6a14 showed an overall effect of DTX but no individual ages showed significant effects
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Discussion
The central role of the Sertoli cells in testis development
and function is now established but how the Sertoli cells
exert control over germ cells, Leydig cells and peritubular
myoid cells remains largely unclear. Similarly, it remains
uncertain how the Sertoli cells themselves are regulated
by both endocrine and paracrine factors although progress
has been made through use of FSHRKO and SCARKO
mice, along with other mouse models. In this study, we
have taken a significant step towards understanding both
functional and control mechanisms associated with the
Sertoli cell through identification of both the Sertoli cell-
specific transcriptome and the regulation of that transcrip-
tome by FSH and androgen.
The approach used here to identify Sertoli cell-specific
transcripts has been used previously to identify the
Leydig cell-specific transcriptome in the rat following
EDS treatment [9, 45] and would be expected to identify
the overwhelming majority of cell-specific transcripts
with the same caveats described previously [9]. Firstly,
transcripts could be erroneously designated as Sertoli
cell-specific if Sertoli cell ablation caused a rapid and
marked decline in transcript expression in another cell
type. This is the main reason why a busulfan-treated,
germ cell-free model was used for this study as Sertoli
cell ablation will cause rapid loss of germ cells from the
testis [2]. Nevertheless, it is possible that a small number
of genes identified as Sertoli cell-specific may be Sertoli
cell-dependent in another cell type. Secondly, any Sertoli
cell-specific transcripts that are highly regulated by the
germ cells and that are markedly down-regulated by
germ cell ablation will not meet the stringency criteria
set here and will be missing from the Sertoli cell-specific
list. Thirdly, it is possible that Sertoli cell ablation could
lead to the onset of expression of (normally) Sertoli cell-
specific transcripts in another cell type. This has been
described previously for a Leydig cell specific transcript
following Leydig cell ablation [36] and the transient re-
appearance of Etd and Defb36 30 days after Sertoli cell
ablation (Fig. 2) suggests that this phenomenon may
occur after Sertoli cell ablation. If similar ectopic expres-
sion of some transcripts occurs soon after Sertoli cell
ablation it would mean that a small subset of Sertoli
cell-specific transcripts may be missing from the list in
Additional file 5. Finally, busulfan is a cytotoxic
compound and it could have direct effects on the
transcriptional regulation of somatic cells which would
affect the data reported here. Mice do not normally
express DTR and would not be expected to be sensitive
to off-target effects of DTX but studies have shown that
DTX can have receptor-independent effects including
weight loss and cochlear damage [46]. It is possible,
therefore, that DTX itself could also directly affect
transcription in the non-target cells of the testis.
The stringency limits used here to define Sertoli cell-
specific transcripts are largely arbitrary but were chosen
to ensure that known Sertoli cell genes were not
excluded. There was some variation in the residual
expression of the Sertoli cell transcripts after Sertoli
cell ablation (eg Wt1) which is a likely indication that
some of these transcipts are also expressed to a small
extent in another cell type. Alternatively, we have
shown that Sertoli-like cells of the tubuli recti do not
express AMH-Cre and are not ablated by DTX in the
iDTR model [2, 3]. For most Sertoli cell-specific
transcripts these cells contribute a low background
level of expression following DTX-treatment but it is
possible that genes such as Wt1 are more highly
expressed in the tubuli recti. Either way, Investigators
can apply higher or lower stringency limits to the data
in Additional file 3 as appropriate to other studies.
The Sertoli cell-specific gene list described here does
not show strong similarity to other Sertoli cell-specific
lists compiled using the RiboTag mouse with only 10–
20% of transcripts matching [41, 42]. Perhaps surpris-
ingly, the two RiboTag studies also show only 17%
agreement between themselves. The Sertoli cell
transcriptome described by Zimmermann et al. [43] is,
however, largely consistent with data reported here. This
transcriptome contains all transcript species expressed
in the Sertoli cells and over 63% of the protein-coding
genes identified here as Sertoli cell-specific are also
included in the overall Sertoli cell transcriptome [43]. In
addition, most of the remaining 37% of non-matching,
Sertoli cell-specifc, protein-coding genes are expressed
at low levels in control animals in our study (expression
of 141 out of a total of 184 of these genes was <1 FPKM
in controls) and may have fallen below the background
expression cutoff used by Zimmermann et al. [43].
Comparing the datasets from the RiboTag mice [41, 42]
with the overall Sertoli cell transcriptome [43] shows
that 82% [41] and 71% [42] of genes identified in the
RiboTag mice are expressed in the Sertoli cells, as may
be expected, but the data outlined here using the iDTR
mouse would suggest that the criteria for selecting
Sertoli cell-specific/enriched genes may not have had
adequate stringency.
Studies using a variety of techniques, including cell
ablation, have highlighted the role that the Sertoli cells
play in regulating testicular function in the adult [2, 3,
46–48]. These Sertoli cell actions include maintenance
of germ cell and Leydig cell populations, stimulation of
peritubular myoid cell activity and maintenance of the
testicular vasculature [4]. How the Sertoli cells act to
orchestrate each of these activities and maintain testicu-
lar function remains largely unknown, however. The
identification, here, of 72 proteins/peptides that are
Sertoli cell-specific and potentially secreted by the cells
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now provides a valuable resource for picking apart cell-
cell interactions in the adult testis. The Sertoli cells also
express 42 different receptor types which illustrates the
complex variety of inputs possible for each cell. These
receptors include some which have been previously
reported to be expressed in the Sertoli cells and to play
a role in testis development and adult function such as
VDR and NR0B1 (DAX1) [49, 50]. Others, such as the
type 2 angiotensin II receptor (AGTR2) have not previ-
ously been shown in the Sertoli cell but mean that the
cells will be responsive to angiotensin. Previous studies
have reported that angiotensinogen (Agt), renin (Ren1)
and angiotensin converting enzyme (Ace) transcripts are
all expressed in the Leydig cells and germ cells of the
testis [51] (and consistent with the RNAseq data
(Additional file 3) reported here). The testis is likely,
therefore, to have an active renin-angiotensin system
and this may be another mechanism by which the Leydig
cells/germ cells can regulate Sertoli cell activity. The list
of receptors also includes 11 olfactory receptors
although transcript levels in the Sertoli cells are gener-
ally low and the function of ectopic olfactory receptors
remains uncertain in many cases [52]. Nevertheless, the
Sertoli cells also specifically express Reep1 at high levels
and REEP1 functions to enhance cell surface expression
of odorant receptors [53] suggesting they may be func-
tional in the Sertoli cells.
Development of the FSHRKO, SCARKO and combined
FSHRKO.SCARKO mouse models has considerably
enhanced our understanding of the endocrine control of
Sertoli cell development, particularly with respect to cell
proliferation and spermatogenesis [12–14, 16]. Studies
into the control of Sertoli cell transcript levels have been
more difficult to interpret, however, since these knockout
mouse models have marked effects on germ cell numbers
and a comprehensive, Sertoli cell-specific transcriptome
has been missing. This has made it challenging to identify,
beyond the limited number of previously known Sertoli
cell-specific transcripts, which transcript changes in each
model are due to altered Sertoli cell activity and which are
due to a reduction in germ cell number. Identification of
the Sertoli cell-specific transcriptome has allowed us now
to examine the effects of the gene-specific knockouts on
Sertoli cell activity. Results show that at 20 days of age in
the mouse, shortly after Sertoli cell proliferation has
ceased and as the blood-testis barrier is forming [54, 55],
normal expression of most Sertoli cell-specific transcripts
is dependent on both androgen and FSH with the effects
of the two hormones either additive or synergistic. Given
that the Sertoli cells regulate germ cell development and
differentiation, this Sertoli cell dependence on hormonal
stimulation around 20 days is consistent with earlier
studies which showed that there is significant germ cell
loss in both FSHRKO and SCARKO mice at 20d [16]. At
20 days the first wave of spermatogenesis is ongoing and it
is characterised by a marked surge in germ cell apoptosis
which is necessary for subsequent normal spermatogen-
esis [56]. Germ cell death during the first wave is regulated
by FSH [57, 58] and, possibly, by androgen [59] and
results described here show that this regulation of sperm-
atogenesis is associated with changes in abundance of
most Sertoli cell-specific transcripts.
Data from animals lacking the AR show that in the
adult androgens remain essential for normal expression
of most Sertoli cell-specific transcripts and in some
cases (eg Corin) the requirement for androgen becomes
more acute as the animals age. This is consistent with
previous data showing that androgen stimulation
through the Sertoli cells is essential for spermatogenesis
in the adult testis [60]. In contrast, the role of FSH in
adult testis biology has been uncertain for a number of
years. Early studies showed that adult Sertoli cells in the
rat or mouse are largely unresponsive to FSH [61]
although FSH was thought to be required for the normal
quantitative maintenance of germ cell production [62,
63]. Subsequent development of mice lacking FSH or its
receptor (FSHR) showed that FSH is not required for
fertility [12, 64] although adult germ cell numbers are
reduced [14, 65], an effect which may be due to loss of
FSH in the adult or to abnormal spermatogenesis during
the first pubertal wave [66]. Results reported here now
show that while FSH is essential for normal Sertoli cell
transcript levels at puberty, cell activity in the adult
mouse appears to be largely unaffected by loss of the
FSHR. In some cases, however, the effect of losing both
FSHR and AR from the Sertoli cells is more marked
than loss of AR alone which indicates that, in the
absence of androgen, FSH can act to regulate Sertoli cell
activity in the adult but cannot overcome the phenotype
associated with androgen deficiency.
Conclusions
The Sertoli cells act to induce testis differentiation
and subsequent development in fetal and post-natal
life [2–6, 67] and they are essential for normal
fertility in the adult. Further progress towards under-
standing the mechanisms which regulate these
functions requires that we recognise how the different
cell types in the testis are able to communicate.
Identification of a robust Sertoli cell-specific
transcriptome takes us closer to that goal and,
combined with the total Sertoli cell transcriptome
published earlier [43], provides us with the tools
necessary to investigate regulation and function of the
Sertoli cell. As an example of the potential offered by
this data we have also shown, using microarray data,
that most Sertoli cell-specific transcripts are FSH-
and androgen-dependent during development and that
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they remain androgen-dependent into adulthood. This
is likely to explain the observation that androgen
action through the Sertoli cells is essential for
spermatocyte progression through meiosis [60] and
suggests that the effect of androgen may be a general
increase in cell activity rather than activation of
specific pathways.
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